NattoPharma to conduct highest-dosage K2 study in cardio clinical trial

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

27 Jul 2021 --- Vitamin K2 may reduce cardiovascular oxidative stress and vascular calcification caused by nicotine intake, such as that from cigarettes or e-cigarettes. This is... Read More

FormattedPicture

BUSINESS NEWS

26 Jul 2021 --- Ingredients by Nature (IBN) has acquired the Sytrinol brand, which uses compounds in citrus peel and palm fruit extracts to support heart health. IBN will now... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

23 Jul 2021 --- Vitamin K2 is poised to emerge “as one of the most important supplemental nutrients,” following the latest research on its role in immunity and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

20 Jul 2021 ---  Euromed’s new lemon-based botanical ingredient Wellemon may have better bioavailability than orange extract, according to a recent clinical study. The... Read More

FormattedPicture

FOOD RESEARCH

13 Jul 2021 --- NattoPharma is highlighting a new study flagging vitamin K2 as a potential method for Alzheimer’s disease (AD) “prevention.” However, the... Read More

trans